Status:
COMPLETED
Neuromuscular Blocking Agents in the Elderly
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Elective Surgery
Eligibility:
All Genders
18+ years
Brief Summary
The number of elderly patients (\>80 years) is increasing and a large proportion of these patients will require surgery and anaestheasia within the next decades. During anaesthesia NMBAs are used to ...
Detailed Description
The number of elderly patients (\>80 years) is increasing and a large proportion of these patients will require surgery and anesthesia within the next decades. Elderly patients are at higher risk of m...
Eligibility Criteria
Inclusion
- Patients \> 18 years old
- Informed consent
- Scheduled for elective surgery (\>1 hour) under general anaesthesia with intubation and use of rocuronium.
- American Society of Anaesthesiologists (ASA) physical status classification I to III
- Can read and understand Danish
Exclusion
- Known allergy to rocuronium
- Neuromuscular disease that may interfere with neuromuscular data
- Indication for rapid sequence induction
Key Trial Info
Start Date :
March 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 8 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03857750
Start Date
March 27 2019
End Date
October 8 2019
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100